Four popular claims checked against the research, from “seed oils are inflammatory” to “you need a high-dose capsule”
By Steven Paul, registered dietitian, The Whole You Dietitian
Scroll through social media for long enough and you will meet two opposite worlds of omega-3 advice. In one, seed oils are quietly poisoning you and only fish fats can rescue you. In the other, plant seeds give you everything you need and fish is full of toxins. Both worlds are built on omega-3 myths that start from a real piece of biology and then stretch it well past what the research shows.
I went through the systematic reviews, the large trials and the UK guidance behind the most common claims. Here is where the evidence lands.
The short answer on omega-3 myths
Seed oils have not been shown to cause inflammation or harm in human studies. Plant omega-3 is a genuine nutrient, but it does not reliably raise the long-chain omega-3 called DHA, while algal oil does. Fish oil capsules lower blood triglycerides, yet in large trials they make little or no difference to overall cardiovascular events, strokes or deaths in the general population, and higher doses come with a small rise in an irregular heart rhythm. In the UK, the main advice remains eating fish, including oily fish, rather than taking a capsule.
First, the three omega-3s you keep hearing about
Omega-3 is a family of fats, and the myths only make sense once you separate its members.
Alpha-linolenic acid, usually shortened to ALA, is the plant form. It is an essential fatty acid, which means your body cannot make it, so it has to come from food. Flaxseed, chia, walnuts and rapeseed oil are good sources.
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the long-chain forms. They are found mainly in oily fish such as salmon, mackerel and sardines. Fish get most of theirs from algae, either directly or by eating smaller fish that ate algae.
DHA has a settled structural role. It is one of the main fats in the membranes of brain cells and of the light-sensing cells in the retina, the layer at the back of the eye that turns light into nerve signals.
Omega-6 is a separate family. Its main member is linoleic acid, the fat found in large amounts in sunflower, corn and soybean oil. This is the fat at the centre of the seed oil debate.
Myth 1: “Linoleic acid turns into arachidonic acid, so seed oils are inflammatory”
This claim starts with something true. The body can convert linoleic acid into arachidonic acid, a longer omega-6 fat. Arachidonic acid is the starting material for eicosanoids, signalling molecules that help switch on and off inflammation, blood clotting and other processes.
The jump from there to “seed oils are inflammatory” is where it falls apart. A systematic review by Rett and Whelan found that in adults eating a Western-style diet, raising linoleic acid intake several-fold, or cutting it by up to 90%, did not change the amount of arachidonic acid in their blood.
There is a twist the posts tend to leave out. Linoleic acid is not the main route by which arachidonic acid reaches your blood. Arachidonic acid is found ready-made only in animal foods, mainly meat, poultry and eggs, with smaller amounts in fish and dairy. A systematic review by Calder and colleagues found that even small extra amounts of this ready-made arachidonic acid raised its level in the blood, something that eating more linoleic acid does not do. The same review found no harmful effects on inflammation, blood clotting or immune function at intakes several times higher than usual, although it noted that there were too few studies for firm conclusions. So the foods some posts recommend in place of seed oils are the direct dietary source of the fat they warn about, and even that has not been shown to cause inflammation at normal intakes.
If eating more linoleic acid inflamed people, you would expect trials to show it. They do not. A systematic review of randomised controlled trials in healthy adults by Johnson and Fritsche found no rise in blood markers of inflammation when people ate more linoleic acid. A later meta-analysis of trials by Su and colleagues reached the same overall conclusion for C-reactive protein (CRP), a protein the liver releases into the blood when inflammation is present.
Long-term studies of large populations point the same way. A pooled analysis of 30 cohort studies, led by Marklund, found that people with more linoleic acid in their blood had a lower risk of dying from cardiovascular disease, and that higher arachidonic acid levels were not linked with higher risk. A separate review of 44 cohorts by Li and colleagues found that higher linoleic acid intake went with modestly lower death rates overall. These are observational studies, so they show a link, not cause and effect.
Myth 1, part two: “So seed oils protect your heart”
It would be easy to swing to the opposite slogan. The evidence here is more nuanced, and it depends on what the seed oil replaces.
The clearest evidence comes from trials that swapped saturated fat for polyunsaturated fat, which in practice mostly means seed oils. The Cochrane review of cutting saturated fat, by Hooper and colleagues, found that doing so for at least two years lowered the combined risk of heart attacks, strokes and other cardiovascular events, and rated that finding moderate certainty. Replacing the saturated fat with polyunsaturated fat appeared to be one of the useful swaps. The same review found little or no effect on deaths.
Not every researcher agrees. Re-analyses of older trials, including the Minnesota Coronary Experiment, found that cholesterol fell but deaths from heart disease did not, and some reviewers argue that the trials showing benefit were not all well controlled. So the balanced summary is this. Seed oils have not been shown to cause harm, and using them in place of saturated fat probably lowers the risk of cardiovascular events, but trials have not shown that it helps people live longer.
Myth 2: “Plant omega-3 is useless, only fish counts”
The kernel of truth here is conversion. Your body can turn some ALA into EPA and, in smaller amounts still, into DHA. Social media posts often quote a precise conversion percentage. The tracer studies behind those numbers are small and give very different results between studies and between men and women, so no single figure is reliable.
What matters more is what happens in practice. A scoping review of plant-based omega-3 sources by Lane and colleagues found that flaxseed oil generally did not raise DHA or the omega-3 index in blood, while algal oil raised both in every study included. The omega-3 index is the percentage of EPA and DHA in the membranes of red blood cells, a common way of measuring long-term omega-3 status. Most of the trials in that review were in people who eat meat, so the findings may not apply fully to vegans.
None of this makes ALA useless. It is still an essential fat in its own right. One of the few health claims that UK law permits for omega-3 is about ALA. It says that ALA contributes to the maintenance of normal blood cholesterol levels, with the benefit linked to a daily intake of 2 g of ALA. Cohort studies have also linked higher ALA intake with lower cardiovascular risk, though that is association rather than proof.
ALA and DHA simply do different jobs, so the useful question is less “plant or fish?” and more “where does my DHA come from?”
Where vegans and vegetarians fit
A 2025 systematic review by Chamorro and colleagues found that vegetarian diets tend to supply more ALA and linoleic acid, yet go with lower blood levels of EPA and DHA, especially in vegans. The same review found that DHA from microalgae raised blood DHA, including during pregnancy and breastfeeding.
Lower blood levels are not the same as a diagnosed deficiency. There is no UK threshold that defines omega-3 deficiency in otherwise healthy adults, and no study I found shows that lower blood DHA in vegans harms health. What the evidence does support is that algal oil is the plant-friendly route to DHA, because algae are where fish get theirs in the first place.
Your diet can sit anywhere on the spectrum from fully plant-based to mostly animal-based. Oily fish, algal oil and plant seeds all have a place, depending on what you eat and why.
Myth 3: “Fish oil capsules protect your heart”
This is the claim that most surprises people, because fish oil has such a good reputation.
The Cochrane review of omega-3 for heart and circulatory disease, by Abdelhamid and colleagues, pooled dozens of randomised trials. It found, with high certainty, that taking extra EPA and DHA makes little or no difference to deaths from any cause or to the overall number of cardiovascular events. It found that deaths from coronary heart disease may be slightly lower, but rated that finding low certainty. The clearest effect was on triglycerides, a type of fat in the blood, which fell.
So why do so many posts say otherwise? Much of it comes from blood-level studies. A pooled analysis of 17 cohorts by Harris and colleagues found that people with the highest blood EPA and DHA had roughly 15 to 18% lower risk of death than those with the lowest. That is a real association, but the authors themselves note that blood levels may partly reflect a generally healthier lifestyle, and trials that raise omega-3 levels with capsules have not reproduced the benefit. Most participants were older white adults, with an average age of 65, which limits how far the finding applies to everyone else.
The same gap appears with the “omega-3 index of 8%” target you may see promoted with home test kits. That figure comes from observational research, not from a UK standard or from trials that treated people to a target.
Some posts point to a trial of a high-dose prescription product. That was a medicine, tested in people with existing heart disease or diabetes and raised triglycerides, so it tells us little about an over-the-counter capsule in a healthy person.
The rhythm and bleeding questions
More is not automatically better. Atrial fibrillation (AF) is an irregular, often fast heart rhythm that raises the risk of stroke. A pooled analysis of large cardiovascular trials by Gencer and colleagues found that omega-3 supplements were linked with a higher risk of AF, more so at doses above 1 g a day.
A larger 2026 meta-analysis of 35 trials, by Abuknesha and colleagues, found the clearest increase in people already at high cardiovascular risk taking more than 1.5 g a day, with an absolute rise of under one percentage point. Whether lower doses carry a small risk is still debated; the two analyses grouped their data differently and reached different answers on that point. People with higher omega-3 levels from their normal diet do not appear to have more AF.
On bleeding, a 2024 meta-analysis of trials by Javaid and colleagues found no overall increase with omega-3 supplements, with a small absolute rise in people on high-dose prescription EPA. If you take a blood thinner or any regular medicine, the right person to check a supplement with is your GP or pharmacist.
What about “omega-3 reduces inflammation”?
Here the evidence is more favourable than for most claims, with one big caveat. Meta-analyses of trials, including one of 68 trials by Li and colleagues and one of 171 trials by AbuMweis and colleagues, found that EPA and DHA supplements lowered blood markers of inflammation such as CRP. The average fall in CRP was small, around a third of a milligram per litre.
A change in a blood marker is not the same as feeling better or avoiding disease, and the trials have not shown that link. “Reduces inflammation” is also not one of the health claims that UK law allows for omega-3, so you should be wary of any product that leads with it.
Brain and mood: the claims that outrun the trials
DHA’s structural role in the brain is settled, and UK law permits the claim that DHA contributes to the maintenance of normal brain function and normal vision, based on 250 mg of DHA a day. That is a statement about normal function, not a promise of better memory.
When trials have given extra omega-3 to adults without dementia, they have generally not found better thinking or memory. A 2024 meta-analysis by Suh and colleagues found no meaningful effect on overall cognitive function. The European Food Safety Authority has also turned down a claim that DHA improves memory, after finding that most of the trials submitted showed no effect.
For depression, the Cochrane review by Appleton and colleagues found a small effect in trials, below the size usually considered clinically meaningful, and rated the evidence very low certainty. Depression is a medical condition that needs proper assessment and care, not a capsule chosen from a social media post.
Myth 4: “Any fish oil will do, and you need a high dose”
Supplement quality does vary. A New Zealand survey by Albert and colleagues found that most fish oil products tested had oxidation levels above the recommended limit, and only a few contained the EPA and DHA stated on the label. A multi-year US analysis by Hands and colleagues found oxidation above the industry limit far more often in flavoured products than in unflavoured ones. Neither survey looked at UK products. Oxidised oil may lose some of its effect on blood fats, but harm to people has not been established.
The chemical form matters a little. In a two-week study, Dyerberg and colleagues found that the re-esterified triglyceride form was absorbed better than the ethyl ester form. All the common forms raise blood EPA and DHA, and taking a capsule with a meal is a reasonable practical step.
Labels need reading closely. A “1,000 mg” capsule usually means 1,000 mg of oil, not 1,000 mg of EPA and DHA, so the figure that matters is the EPA and DHA line on the back.
As for dose, there is no evidence that the general population needs the 2 g a day or more promoted in many posts, and the rhythm findings above are a reason for caution. The British Dietetic Association does not recommend omega-3 supplements for the general UK population. Where someone chooses one anyway, its guidance suggests around 450 mg of EPA and DHA a day, roughly what one to two portions of fish a week provide.
What UK guidance says
UK advice is to eat at least two portions of fish a week, one of them oily, with a portion around 140 g. There are upper limits on oily fish for girls and for women who are pregnant, breastfeeding or planning a pregnancy, because of pollutants that build up in oily fish, and certain large predatory fish carry extra advice because of mercury. Fish also bring protein, vitamin D, iodine and selenium, which a capsule does not.
The main takeaway
Most omega-3 myths take a real mechanism and treat it as a proven health outcome. Seed oils have not been shown to inflame or harm people, and using them in place of saturated fat probably lowers cardiovascular risk, though trials have not shown it helps people live longer. Plant ALA has its own role but does not reliably raise DHA, and algal oil fills that gap for people who do not eat fish. Fish oil capsules change blood fats and markers, yet the big trials show little effect on overall cardiovascular events, strokes or deaths in the general population, and more is not better. Food first remains the UK position.
This article explains what the evidence shows in general. It is not personalised advice for your own situation.
If you’re looking to improve your diet and lifestyle, that’s exactly what a registered dietitian specialises in.
If this cleared up a claim you have seen online, save it for the next time an omega-3 post lands in your feed.
I offer online (virtual) dietetic appointments across the UK. You can book a free 15-minute discovery call through this website.
This content is for educational and informational purposes only and does not substitute for professional medical advice, diagnosis, or treatment.
References
Abdelhamid, A.S. et al. (2020) ‘Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease’, Cochrane Database of Systematic Reviews, 3(3), CD003177. doi:10.1002/14651858.CD003177.pub5.
AbuMweis, S. et al. (2018) ‘Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials’, Journal of Human Nutrition and Dietetics, 31(1), pp. 67-84. doi:10.1111/jhn.12493.
Abuknesha, N.R. et al. (2026) ‘Effects of omega-3 fatty acid treatment on risk for atrial fibrillation: an updated meta-analysis of 35 trials including 114 592 individuals’, Circulation: Arrhythmia and Electrophysiology, 19(8), e014785. doi:10.1161/CIRCEP.125.014785.
Albert, B.B. et al. (2015) ‘Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA’, Scientific Reports, 5, 7928. doi:10.1038/srep07928.
Appleton, K.M. et al. (2021) ‘Omega-3 fatty acids for depression in adults’, Cochrane Database of Systematic Reviews, 11(11), CD004692. doi:10.1002/14651858.CD004692.pub5.
British Dietetic Association (2021) Omega-3: Food Fact Sheet. Available at: https://www.bda.uk.com/resource/omega-3.html (Accessed: 22 October 2026).
Calder, P.C. et al. (2019) ‘A systematic review of the effects of increasing arachidonic acid intake on PUFA status, metabolism and health-related outcomes in humans’, British Journal of Nutrition, 121(11), pp. 1201-1214. doi:10.1017/S0007114519000692.
Chamorro, R. et al. (2025) ‘Vegetarian diets and their effect on n-3 polyunsaturated fatty acids status in humans: systematic review’, Lipids, 61(1), pp. 29-53. doi:10.1002/lipd.70009.
Department of Health and Social Care (2026) Great Britain nutrition and health claims (NHC) register. Available at: https://www.gov.uk/government/publications/great-britain-nutrition-and-health-claims-nhc-register (Accessed: 22 October 2026).
Dyerberg, J. et al. (2010) ‘Bioavailability of marine n-3 fatty acid formulations’, Prostaglandins, Leukotrienes and Essential Fatty Acids, 83(3), pp. 137-141. doi:10.1016/j.plefa.2010.06.007.
EFSA Panel on Dietetic Products, Nutrition and Allergies (2016) ‘Docosahexaenoic acid and improvement of memory function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006’, EFSA Journal, 14, 4455. doi:10.2903/j.efsa.2016.4455.
Gencer, B. et al. (2021) ‘Effect of long-term marine ω-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes’, Circulation, 144(25), pp. 1981-1990. doi:10.1161/CIRCULATIONAHA.121.055654.
Hands, J.M. et al. (2023) ‘A multi-year rancidity analysis of 72 marine and microalgal oil omega-3 supplements’, Journal of Dietary Supplements, 21(2), pp. 195-206. doi:10.1080/19390211.2023.2252064.
Harris, W.S. et al. (2021) ‘Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies’, Nature Communications, 12(1), 2329. doi:10.1038/s41467-021-22370-2.
Hooper, L. et al. (2020) ‘Reduction in saturated fat intake for cardiovascular disease’, Cochrane Database of Systematic Reviews, 8(8), CD011737. doi:10.1002/14651858.CD011737.pub3.
Javaid, M. et al. (2024) ‘Bleeding risk in patients receiving omega-3 polyunsaturated fatty acids: a systematic review and meta-analysis of randomized clinical trials’, Journal of the American Heart Association, 13(10), e032390. doi:10.1161/JAHA.123.032390.
Johnson, G.H. and Fritsche, K. (2012) ‘Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials’, Journal of the Academy of Nutrition and Dietetics, 112(7), pp. 1029-1041. doi:10.1016/j.jand.2012.03.029.
Lane, K.E. et al. (2021) ‘Bioavailability and conversion of plant based sources of omega-3 fatty acids: a scoping review to update supplementation options for vegetarians and vegans’, Critical Reviews in Food Science and Nutrition, 62(18), pp. 4982-4997. doi:10.1080/10408398.2021.1880364.
Li, J. et al. (2020) ‘Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies’, American Journal of Clinical Nutrition, 112(1), pp. 150-167. doi:10.1093/ajcn/nqz349.
Li, K. et al. (2014) ‘Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysis’, PLoS ONE, 9(2), e88103. doi:10.1371/journal.pone.0088103.
Marklund, M. et al. (2019) ‘Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality’, Circulation, 139(21), pp. 2422-2436. doi:10.1161/CIRCULATIONAHA.118.038908.
NHS (2026) Fish and shellfish. Available at: https://www.nhs.uk/live-well/eat-well/food-types/fish-and-shellfish-nutrition/ (Accessed: 22 October 2026).
Ramsden, C.E. et al. (2016) ‘Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73)’, BMJ, 353, i1246. doi:10.1136/bmj.i1246.
Rett, B.S. and Whelan, J. (2011) ‘Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review’, Nutrition and Metabolism, 8, 36. doi:10.1186/1743-7075-8-36.
Scientific Advisory Committee on Nutrition and Committee on Toxicity (2004) Advice on fish consumption: benefits and risks. London: TSO.
Su, H. et al. (2017) ‘Dietary linoleic acid intake and blood inflammatory markers: a systematic review and meta-analysis of randomized controlled trials’, Food and Function, 8(9), pp. 3091-3103. doi:10.1039/c7fo00433h.
Suh, S.W. et al. (2024) ‘The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis’, BMC Medicine, 22(1), 109. doi:10.1186/s12916-024-03296-0.